Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee Hears Bill to Ban Prior Authorization for FDA-Approved HIV Antivirals
Summary
The House Healthcare and Wellness Committee heard Substitute Senate Bill 6,183, which would require health plans—including those for public and school employees—to cover FDA-approved HIV antiviral drugs without prior authorization, step therapy, or other utilization management beginning Jan. 1, 2027; the prime sponsor framed it as part of efforts to end HIV in Washington.
The House Healthcare and Wellness Committee convened a public hearing on Substitute Senate Bill 6,183, which would prohibit health plans issued or renewed on or after Jan. 1, 2027, from imposing prior authorization, step-therapy or other utilization-management protocols on FDA-approved antiviral drugs used to treat or prevent HIV.
Kim Weidner, committee staff, told legislators that…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
